Company intelligence / Profile preview

Schmid Pharma

Ownership: Private
Development stage: Other

Overview

Schmid Pharma is a family-owned pharmaceutical company founded in 2015. It specializes in high-quality niche products and innovative drug delivery systems such as orodispersible film tablets. The company acts as an exclusive agent for various specialized pharma partners worldwide, focusing on licensing and supplying both OTC and prescription drugs—including generics like paracetamol + codeine phosphate, oseltamivir capsules, clozapine tablets—and offers private label options. Its business model centers on strategic partnerships rather than direct R&D or clinical development of new molecular entities.

Therapeutic areas: EndocrinologyPsychiatryRheumatologyNeurologyInfectious Diseases
Modalities: Small moleculeOligonucleotidePeptides
Industry: Contract Manufacturing Organization

Beyond the preview

Go deeper on Schmid Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Schmid Pharma.

Explore the full profile